DEFINITIVE PROXY STATEMENT

Company

Aptose Biosciences Inc.

Filed

April 24, 2020

Period of Report

June 2, 2020

Accession Number

0001171843-20-002838

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →